These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17407427)

  • 41. Methamphetamine precursor regulation: are we controlling or diverting the drug problem?
    McKetin R
    Addiction; 2008 Apr; 103(4):521-3. PubMed ID: 18339098
    [No Abstract]   [Full Text] [Related]  

  • 42. Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention.
    Zhu L; Ni T; Guan F
    Am J Psychiatry; 2024 Feb; 181(2):168. PubMed ID: 38298079
    [No Abstract]   [Full Text] [Related]  

  • 43. Committee Opinion No. 479: Methamphetamine abuse in women of reproductive age.
    Obstet Gynecol; 2011 Mar; 117(3):751-755. PubMed ID: 21343793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The burden and management of crystal meth use.
    Buxton JA; Dove NA
    CMAJ; 2008 Jun; 178(12):1537-9. PubMed ID: 18519899
    [No Abstract]   [Full Text] [Related]  

  • 45. Vigilance needed with methamphetamine-associated psychosis.
    Elefante RJO; Nolan S; Bach PJ
    CMAJ; 2023 Oct; 195(39):E1356. PubMed ID: 37816525
    [No Abstract]   [Full Text] [Related]  

  • 46. Use ecology and drug use motivations of methamphetamine users admitted to substance abuse treatment facilities in Los Angeles: an emerging profile.
    von MC; Brecht ML; Anglin MD
    J Addict Dis; 2002; 21(1):45-60. PubMed ID: 11831499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methamphetamine-associated cardiomyopathy.
    Won S; Hong RA; Shohet RV; Seto TB; Parikh NI
    Clin Cardiol; 2013 Dec; 36(12):737-42. PubMed ID: 24037954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study.
    Okada N; Takahashi K; Nishimura Y; Koike S; Ishii-Takahashi A; Sakakibara E; Satomura Y; Kinoshita A; Takizawa R; Kawasaki S; Nakakita M; Ohtani T; Okazaki Y; Kasai K
    Addict Biol; 2016 Mar; 21(2):489-503. PubMed ID: 25619621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ocular manifestations of crystal methamphetamine use.
    Hazin R; Cadet JL; Kahook MY; Saed D
    Neurotox Res; 2009 Feb; 15(2):187-91. PubMed ID: 19384581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychostimulant use and the brain.
    Lappin JM; Sara GE
    Addiction; 2019 Nov; 114(11):2065-2077. PubMed ID: 31321819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
    Yang M; Yang C; Liu T; London ED
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149
    [No Abstract]   [Full Text] [Related]  

  • 52. [Stimulant dependence].
    Kishimoto H
    Ryoikibetsu Shokogun Shirizu; 2003; (40):505-6. PubMed ID: 14626171
    [No Abstract]   [Full Text] [Related]  

  • 53. Epidemiology of methamphetamine abuse in Missouri.
    Topolski JM
    Mo Med; 2007; 104(1):82-8. PubMed ID: 17410832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Restricting the sale of pseudoephedrine to prevent methamphetamine production.
    Colker AC
    NCSL Legisbrief; 2005 Feb; 13(7):1-2. PubMed ID: 15726724
    [No Abstract]   [Full Text] [Related]  

  • 55. The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
    Voce A; McKetin R; Burns R; Castle D; Calabria B
    Psychiatry Res; 2018 Jul; 265():19-24. PubMed ID: 29680513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The methamphetamine epidemic and dentistry.
    Klasser GD; Epstein JB
    Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction.
    Stock AK; Beste C
    Arch Toxicol; 2017 Jul; 91(7):2707-2709. PubMed ID: 28444486
    [No Abstract]   [Full Text] [Related]  

  • 59. Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa.
    Plüddemann A; Dada S; Parry CD; Kader R; Parker JS; Temmingh H; van Heerden S; de Clercq C; Lewis I
    Afr J Psychiatry (Johannesbg); 2013 Jan; 16(1):45-9. PubMed ID: 23417636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methamphetamine: Effects on the brain, gut and immune system.
    Prakash MD; Tangalakis K; Antonipillai J; Stojanovska L; Nurgali K; Apostolopoulos V
    Pharmacol Res; 2017 Jun; 120():60-67. PubMed ID: 28302577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.